About

Vårt oppdrag er å oppdage, utvikle og levere innovative medisiner som hjelper pasienter å vinne over alvorlige sykdommer.

Address

Bristol Myers Squibb Norway
Lysaker Torg 35
1366 Lysaker

Contact details

Medical Information phone number
+47 23 12 06 37

Medical Information website
Bristol Myers Squibb Online Medisinsk Informasjon for Norge

Medical Information email
medinfo.norway@bms.com

Adverse events and product complaints

For å rapportere om en bivirkning, vennligst kontakt oss på

Adverse event phone number
+47 23 12 06 37

Adverse event email
medinfo.norway@bms.com

Website
https://www.bms.com/no

BMS products

Medicinal products marked withare subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

Azactam®

Baraclude®
(entecavir)

Camzyos®
(mavacamten)

Eliquis® (Co-Promoted Pfizer)
(apixaban)

Empliciti®
(elotuzumab)

Imnovid®
(pomalidomide)

Inrebic®
(fedratinib)

Kenacort-T®

Nulojix®
(belatacept)

Opdivo®
(nivolumab)

Opdualag®
(nivolumab + relatlimab)

Orencia®
(abatacept)

Reblozyl®
(luspatercept)

Revlimid®
(lenalidomide)

Sotyktu®
(deucravacitinib)

Sprycel®
(dasatinib)

Thalidomide BMS
(thalidomide)

Vidaza®
(azacitidine)

Yervoy®
(ipilimumab)

Zeposia®
(ozanimod)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Page last updated: 16/04/2024